Literature DB >> 21385286

The impact of young age on outcomes in esophageal and junctional cancer.

C L Donohoe1, E MacGillycuddy, J V Reynolds.   

Abstract

It is not known whether patients diagnosed with esophageal and junctional cancer aged younger than 50 years have a more aggressive disease phenotype and thus poorer outcomes following treatment. Prospectively maintained database records of all patients diagnosed with esophageal carcinoma (n= 2129) over a 20-year period (1990-2009) in a single institution were analyzed. Patients aged less than 50 years at diagnosis (n= 170) were compared with those over 50 years with respect to clinicopathological stage and oncological outcomes. There was a significantly greater proportion of male patients (77.4 vs. 64.7%) among the younger group (P= 0.001). Patients were more likely to be diagnosed with an esophagogastric junction tumor (P= 0.002) and to have symptoms for a longer period prior to diagnosis (24.0 vs. 17.8 weeks, P= 0.03) if they were aged less than 50 years old. There was no significant difference in clinicopathological staging including Tumor-Nodal-Metastasis (TNM) stage, differentiation, and lymphatic and perineural invasion other than a greater likelihood of venous invasion in the older group (P= 0.002). Younger patients were more likely to be treated with curative rather than palliative intent (66.9 vs. 51.1%, P < 0.001). The disease-specific survival of patients younger than 50 years treated with curative intent was significantly greater than older patients (median 35 vs. 21 months, P= 0.04), except for the subgroup of patients aged less than 35 years (n= 18) who have reduced survival. Multivariate analysis revealed independent factors related to the difference in survival included sex, age, advanced T stage, and nodal metastases (P < 0.05). A consistent proportion of esophageal cancer patients are diagnosed aged less than 50 years old over time (1990-2009). Few phenotypic tumor differences were noted between the groups. With an aggressive approach to management, survival is significantly greater than in the older cohort, although outcomes are poorer in those aged below 35 years.
© 2011 Copyright the Authors. Journal compilation © 2011, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Year:  2011        PMID: 21385286     DOI: 10.1111/j.1442-2050.2011.01183.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  4 in total

1.  Influence of young age on outcome after esophagectomy for cancer.

Authors:  Anna M J van Nistelrooij; Elrozy R Andrinopoulou; Jan J B van Lanschot; Hugo W Tilanus; Bas P L Wijnhoven
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

Review 2.  Role of stenting in the palliation of gastroesophageal junction cancer: A brief review.

Authors:  Theodoros E Pavlidis; Efstathios T Pavlidis
Journal:  World J Gastrointest Surg       Date:  2014-03-27

3.  Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma.

Authors:  Yuan-Ning Guo; Dong-Ping Tian; Qing-Yun Gong; Hao Huang; Peng Yang; Shao-Bin Chen; Salem Billan; Jia-Yu He; Hai-Hua Huang; Pan Xiong; Wen-Ting Lin; Dan Guo; Moshe Marom; Ziv Gil; Min Su
Journal:  Ann Surg Oncol       Date:  2020-06-09       Impact factor: 5.344

4.  Advanced Esophageal Squamous Cell Carcinoma in Young Female Patient With Durable Complete Response on Treatment.

Authors:  Natalia Jankarashvili; Tamar Melkadze; Mariam Tchiabrishvili; Armaz Mariamidze; Giorgi Arveladze
Journal:  Cureus       Date:  2021-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.